exponentially increased in the past decade, and are a major concern in hospitals. In the first
part of the work, we compared the proteome profile of MDR and susceptible clinical isolates
of Escherichia coli and Klebsiella pneumoniae in order to identify possible biological
processes associated with drug resistance and susceptible phenotypes, using a label-free
approach. In the second part, we used an immunoproteomics approach to identify …